GE Healthcare Gets FDA Clearance for 3D, Motion-Insensitive Imaging Applications
2022年9月30日 - 12:52AM
Dow Jones News
By Kathryn Hardison
General Electric Co.'s healthcare business has received
clearance from the Food and Drug Administration for its AIR Recon
DL for 3D and Propeller imaging sequences.
GE Healthcare said Thursday that the new applications will
create better MRI image quality, shorter scan times and an enhanced
patient experience.
The company said that the expanded compatibility from 2D to 3D
imaging sequences will allow physicians to quickly diagnose
patients with improved signal-to-noise ratio and sharpness. The
compatibility with Propeller, a motion-insensitive imaging
sequence, will also improve imaging for patients who have
difficulty remaining still for the duration of the scan, the
company said.
GE Healthcare is a $17.7 billion business under GE focused on
medical technology, pharmaceutical diagnostics and digital
solutions.
Write to Kathryn Hardison at kathryn.hardison@wsj.com
(END) Dow Jones Newswires
September 29, 2022 11:37 ET (15:37 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
GE Aerospace (NYSE:GE)
過去 株価チャート
から 3 2024 まで 4 2024
GE Aerospace (NYSE:GE)
過去 株価チャート
から 4 2023 まで 4 2024
